Literature DB >> 10631232

The role of BAL in the diagnosis of pulmonary mucormycosis.

M Glazer1, S Nusair, R Breuer, J Lafair, Y Sherman, N Berkman.   

Abstract

Five patients with pulmonary mucormycosis diagnosed during life are described. All had underlying predisposing conditions: either posttransplant or hematologic malignancies. In all cases, the diagnosis was made using fiberoptic bronchoscopy. In three patients, BAL was diagnostic. In two of these patients, the diagnosis was made by identifying the typical hyphae of mucormycosis in the BAL fluid alone. Transbronchial biopsy was diagnostic in three patients. Treatment was based on IV antifungal chemotherapy together with surgical removal of involved lung tissue whenever feasible. The clinical outcome of these patients was dismal and was determined primarily by the underlying condition.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10631232     DOI: 10.1378/chest.117.1.279

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Usefulness of molecular biology performed with formaldehyde-fixed paraffin embedded tissue for the diagnosis of combined pulmonary invasive mucormycosis and aspergillosis in an immunocompromised patient.

Authors:  Véronique Hofman; Abdelmajid Dhouibi; Catherine Butori; Bernard Padovani; Martine Gari-Toussaint; Dea Garcia-Hermoso; Michèle Baumann; Nicolas Vénissac; Gieri Cathomas; Paul Hofman
Journal:  Diagn Pathol       Date:  2010-01-08       Impact factor: 2.644

Review 2.  Zygomycosis: the re-emerging fungal infection.

Authors:  M Chayakulkeeree; M A Ghannoum; J R Perfect
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

3.  Aspergillus and mucormycosis presenting with normal chest X-ray in an immunocompromised host.

Authors:  Vipin Gupta; Natarajan Rajagopalan; Mahantesh Patil; C Shivaprasad
Journal:  BMJ Case Rep       Date:  2014-04-09

4.  Fatal Pulmonary Mucormycosis due to Rhizopus homothallicus.

Authors:  Fabrice Compain; Nawel Aït-Ammar; Françoise Botterel; Laure Gibault; Francoise Le Pimpec Barthes; Eric Dannaoui
Journal:  Mycopathologia       Date:  2017-06-03       Impact factor: 2.574

5.  Pulmonary mucormycosis mimicking as pulmonary tuberculosis: a case report.

Authors:  Rajiv Garg; Rungmei Sk Marak; Sanjay Kumar Verma; Jagdeep Singh; Rajendra Prasad
Journal:  Lung India       Date:  2008-07

6.  Automated and manual methods of DNA extraction for Aspergillus fumigatus and Rhizopus oryzae analyzed by quantitative real-time PCR.

Authors:  Andrea Francesconi; Miki Kasai; Susan M Harrington; Mara G Beveridge; Ruta Petraitiene; Vidmantas Petraitis; Robert L Schaufele; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2008-03-19       Impact factor: 5.948

7.  Pulmonary multinodular mucormycosis in type 1 diabetic patient with diabetic ketoacidosis.

Authors:  N Kebapci; B Efe; F Alataş; M Açikalin; N Kiraz
Journal:  J Endocrinol Invest       Date:  2007-03       Impact factor: 4.256

8.  Pulmonary tuberculosis and mucormycosis co-infection in a diabetic patient.

Authors:  Deepak Aggarwal; Jagdish Chander; Ashok K Janmeja; Rahul Katyal
Journal:  Lung India       Date:  2015 Jan-Feb

9.  Pulmonary mucormycosis diagnosed by convex probe endobronchial ultrasound-guided fine needle aspiration of cavity wall.

Authors:  Vidya Nair; Rahul Kumar Sharma; Arjun Khanna; Deepak Talwar
Journal:  Lung India       Date:  2017 Mar-Apr

10.  Reply: The Reversed Halo Sign and the Bronchus Sign: The Eyes See Only What the Mind Knows.

Authors:  Shraddha Narechania; Christine E Koval; Neal F Chaisson
Journal:  Ann Am Thorac Soc       Date:  2019-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.